Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Strong
Garp
Very Strong
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Strong
Earnings
Very Strong
Dividends
Very Weak
Capital Efficiency
Very Strong
Balance Sheet
Weak
Website
Halozyme Therapeutics, Inc.
Telephone
1.858.794.8889
Address
12390 El Camino Real, San Diego, CA 92130
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 51.06 - 82.22
Trade Value (12mth)
US$33,398,378.00
1 week
2.4%
1 month
0.47%
YTD
-2.25%
1 year
27.44%
All time high
82.22
EPS 3 yr Growth
79.00%
EBITDA Margin
64.80%
Operating Cashflow
$652m
Free Cash Flow Return
31.70%
ROIC
15.40%
Interest Coverage
49.90
Quick Ratio
3.70
Shares Outstanding (Fully Diluted)
123m
HALO Sector
Healthcare
Next Company Report Date
23-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 12 May 26 | |
| 12 May 26 | |
| 12 May 26 | |
| 12 May 26 | |
| 12 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | 2.13 | 3.5 | 2.64 | | | | ||
EPS (Fully Diluted) | $ | | | | | 2.1 | 3.43 | 2.56 | | | | ||
Growth | % | | | | | 44.5 | 64 | -24.5 | | | | ||
PE | X | | | | | 17.6 | 13.9 | 26.3 | | | | ||
EV/EBITDA | X | | | | | 14.5 | 11.2 | 11.4 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
